These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15262143)

  • 21. Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance?
    Kohorn EI
    Gynecol Oncol; 2002 Apr; 85(1):36-9. PubMed ID: 11925117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].
    Xiang Y; Wan XR; Sun ZJ; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):79-82. PubMed ID: 15840283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Single methotrexate chemotherapy for low-risk gestational trophoblastic tumor].
    Lu WG; Ding ZM; Xie X; Ye DF; Chen HZ; Feng SW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):414-7. PubMed ID: 12974085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia.
    Lurain JR
    Am J Obstet Gynecol; 2011 Jan; 204(1):11-8. PubMed ID: 20739008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
    Chan KK; Huang Y; Tam KF; Tse KY; Ngan HY
    Am J Obstet Gynecol; 2006 Nov; 195(5):1282-6. PubMed ID: 16723109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of low-risk gestational trophoblastic neoplasia in indigent women.
    Schorge JO; Lea JS; Farrar DF; King MR; Coleman RL; Miller DS
    J Reprod Med; 2003 Oct; 48(10):780-4. PubMed ID: 14628732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined methotrexate-dactinomycin: an effective therapy for low-risk gestational trophoblastic neoplasia.
    Eiriksson L; Wells T; Steed H; Schepansky A; Capstick V; Hoskins P; Pike J; Swenerton K
    Gynecol Oncol; 2012 Mar; 124(3):553-7. PubMed ID: 22079360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate, bleomycin, and Etoposide in the treatment of gestational trophoblastic neoplasia.
    Ngan HY; Tam KF; Lam KW; Chan KK
    Obstet Gynecol; 2006 May; 107(5):1012-7. PubMed ID: 16648404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity.
    Chalouhi GE; Golfier F; Soignon P; Massardier J; Guastalla JP; Trillet-Lenoir V; Schott AM; Raudrant D
    Am J Obstet Gynecol; 2009 Jun; 200(6):643.e1-6. PubMed ID: 19393597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum hCG level and rising world health organization score at second-line chemotherapy (pulse dactinomycin): poor prognostic factors for methotrexate-failed low-risk gestational trophoblastic neoplasia.
    Kang WD; Kim CH; Cho MK; Kim JW; Cho HY; Kim YH; Choi HS; Kim SM
    Int J Gynecol Cancer; 2010 Nov; 20(8):1424-8. PubMed ID: 21051988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of patients with metastatic gestational trophoblastic tumor.
    Ghaemmaghami F; Behtash N; Soleimani K; Hanjani P
    Gynecol Oncol; 2004 Jul; 94(1):187-90. PubMed ID: 15262140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole.
    Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H
    Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia.
    Winter MC; Tidy JA; Hills A; Ireson J; Gillett S; Singh K; Hancock BW; Coleman RE
    Gynecol Oncol; 2016 Dec; 143(3):565-570. PubMed ID: 27756557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy regimens used in the treatment of gestational trophoblastic neoplasia at Philippine General Hospital: treatment outcomes and toxicity.
    Cagayan MS; Gacoba MC
    J Reprod Med; 2006 Nov; 51(11):907-18. PubMed ID: 17165439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weekly intramuscular methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
    Mohit M; Sarraf Z; Sheikhi G; Robati M; Vasheghani-Farahani A
    Arch Gynecol Obstet; 2009 Nov; 280(5):775-80. PubMed ID: 19263063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary.
    Fülöp V; Szigetvŕi I; Szepesi J; Török M; Berkowitz RS
    J Reprod Med; 2008 Jul; 53(7):541-6. PubMed ID: 18720931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia.
    Li L; Wan X; Feng F; Ren T; Yang J; Zhao J; Jiang F; Xiang Y
    BMC Cancer; 2018 May; 18(1):585. PubMed ID: 29792175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Outcome of gestational trophoblastic neoplasia patients with residual lung tumor after completion of treatment].
    Yang JJ; Xiang Y; Wan XR; Li JG; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):26-8. PubMed ID: 17331417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
    Al-Husaini H; Soudy H; Darwish A; Ahmed M; Eltigani A; Edesa W; Elhassan T; Omar A; Elghamry W; Al-Hashem H; Al-Hayli S; Madkhali I; Ahmad S; Al-Badawi IA
    Clin Transl Oncol; 2015 May; 17(5):409-15. PubMed ID: 25398721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.